Acetaminophen
Colorimetry, Acetaminophen. 510(k) K202644, from Sekisui Diagnostics P.E.I., Inc. (Charlottetown, CA). Product code LDP, class 2.
As of Nov 20, 2026, K202644 is an FDA 510(k) held by Sekisui Diagnostics P.E.I., Inc., substantially equivalent on Feb 18, 2022 after 525 days, with no recalls tied to it in FDA's recall database.
- Review time: 525 days
- Recalls: 0
The Acetaminophen assay is used for the quantitative determination of acetaminophen in human serum or plasma on the ARCHITECT c Systems. The Acetaminophen assay is to be used as an aid in the diagnosis and treatment of acetaminophen overdose toxicity.
- Acetaminophen L3K Assay, and Acetaminophen L3K Assay, Models 506-10, 506-30K081938 · Genzyme Diagnostics P.E.I., Inc. · May 1, 2009
- Atellica CH Acetaminophen 2 (ACTM)K261364 · Siemens Healthcare Diagnostics, Inc. · Jul 24, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 11, 2020
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3030
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files